Frontcourt Group

Aria CV, Inc. is a medical device company based in St. Paul, Minnesota, specializing in treatments for pulmonary arterial hypertension (PAH). Founded in 2010 by Drs. John Scandurra and Karl Vollmers, the company has developed an innovative implantable cardiovascular device aimed at reducing the workload on the right side of the heart. This device holds the potential to enhance both the survival and quality of life for patients suffering from pulmonary hypertension. Aria CV has secured an exclusive license for certain patents from the University of Minnesota, reflecting its commitment to advancing medical technology in this critical area of healthcare.

SPR Therapeutics is a medical device company that develops and commercializes peripheral nerve stimulation (PNS) therapies for pain management. It focuses on non-narcotic, reversible treatments for acute and chronic pain, including post-surgical pain and neuropathic pain, as well as phantom limb and musculoskeletal pain. The SMARTPATCH PNS system provides short-term, minimally invasive nerve stimulation to relieve pain, and the portfolio includes the Micropulse implantable PNS system for longer-term therapy and Smartpatch MicroLead, a coiled-wire lead designed to promote rapid tissue ingrowth. Founded in 2009 and headquartered in Cleveland, Ohio, with additional locations in the Research Triangle area and Minneapolis, SPR Therapeutics aims to offer safe, effective, and affordable pain relief as an alternative to opioids and invasive procedures.